nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—HBA1—blood plasma—hepatitis B	0.0332	0.186	CbGeAlD
Mefloquine—HBA2—blood plasma—hepatitis B	0.0305	0.171	CbGeAlD
Mefloquine—CYP19A1—semen—hepatitis B	0.0255	0.143	CbGeAlD
Mefloquine—Respiratory disorder—Lamivudine—hepatitis B	0.0242	0.0506	CcSEcCtD
Mefloquine—Respiration abnormal—Lamivudine—hepatitis B	0.0228	0.0477	CcSEcCtD
Mefloquine—Foetor hepaticus—Adefovir Dipivoxil—hepatitis B	0.0139	0.0291	CcSEcCtD
Mefloquine—HBA1—blood—hepatitis B	0.0122	0.0682	CbGeAlD
Mefloquine—Loose stools—Telbivudine—hepatitis B	0.012	0.0251	CcSEcCtD
Mefloquine—Liver disorder—Adefovir Dipivoxil—hepatitis B	0.0116	0.0242	CcSEcCtD
Mefloquine—HBA2—blood—hepatitis B	0.0112	0.0626	CbGeAlD
Mefloquine—HBA1—liver—hepatitis B	0.0095	0.0533	CbGeAlD
Mefloquine—Influenza-like symptoms—Telbivudine—hepatitis B	0.00932	0.0195	CcSEcCtD
Mefloquine—HBA2—liver—hepatitis B	0.00873	0.049	CbGeAlD
Mefloquine—Hepatocellular injury—Adefovir Dipivoxil—hepatitis B	0.0079	0.0165	CcSEcCtD
Mefloquine—Suicide—Lamivudine—hepatitis B	0.00723	0.0151	CcSEcCtD
Mefloquine—BCHE—blood plasma—hepatitis B	0.00669	0.0375	CbGeAlD
Mefloquine—Pregnancy—Lamivudine—hepatitis B	0.00661	0.0138	CcSEcCtD
Mefloquine—Hepatic failure—Entecavir—hepatitis B	0.00654	0.0137	CcSEcCtD
Mefloquine—Influenza like illness—Telbivudine—hepatitis B	0.00646	0.0135	CcSEcCtD
Mefloquine—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.00638	0.0133	CcSEcCtD
Mefloquine—Completed suicide—Lamivudine—hepatitis B	0.00638	0.0133	CcSEcCtD
Mefloquine—ADORA2A—blood—hepatitis B	0.00581	0.0326	CbGeAlD
Mefloquine—ADORA2A—liver—hepatitis B	0.00454	0.0255	CbGeAlD
Mefloquine—CYP3A4—blood plasma—hepatitis B	0.0045	0.0253	CbGeAlD
Mefloquine—Renal failure—Entecavir—hepatitis B	0.00445	0.0093	CcSEcCtD
Mefloquine—CYP2D6—blood plasma—hepatitis B	0.00443	0.0249	CbGeAlD
Mefloquine—Cramp muscle—Telbivudine—hepatitis B	0.00435	0.00908	CcSEcCtD
Mefloquine—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00435	0.00908	CcSEcCtD
Mefloquine—Hepatobiliary disease—Entecavir—hepatitis B	0.00429	0.00895	CcSEcCtD
Mefloquine—Muscular weakness—Telbivudine—hepatitis B	0.00426	0.0089	CcSEcCtD
Mefloquine—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00418	0.00873	CcSEcCtD
Mefloquine—Drug interaction—Lamivudine—hepatitis B	0.00404	0.00844	CcSEcCtD
Mefloquine—Hearing impaired—Lamivudine—hepatitis B	0.00394	0.00823	CcSEcCtD
Mefloquine—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.0039	0.00815	CcSEcCtD
Mefloquine—Renal failure—Telbivudine—hepatitis B	0.00366	0.00764	CcSEcCtD
Mefloquine—Neuropathy peripheral—Telbivudine—hepatitis B	0.00365	0.00762	CcSEcCtD
Mefloquine—Alopecia—Entecavir—hepatitis B	0.00359	0.00751	CcSEcCtD
Mefloquine—Mental disorder—Entecavir—hepatitis B	0.00356	0.00744	CcSEcCtD
Mefloquine—Malnutrition—Entecavir—hepatitis B	0.00354	0.0074	CcSEcCtD
Mefloquine—Aplastic anaemia—Lamivudine—hepatitis B	0.00352	0.00735	CcSEcCtD
Mefloquine—Neuropathy—Lamivudine—hepatitis B	0.00352	0.00735	CcSEcCtD
Mefloquine—Hepatobiliary disease—Telbivudine—hepatitis B	0.00352	0.00735	CcSEcCtD
Mefloquine—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00345	0.00722	CcSEcCtD
Mefloquine—CYP19A1—blood—hepatitis B	0.0034	0.0191	CbGeAlD
Mefloquine—Connective tissue disorder—Telbivudine—hepatitis B	0.00328	0.00686	CcSEcCtD
Mefloquine—ABCB1—blood plasma—hepatitis B	0.00319	0.0179	CbGeAlD
Mefloquine—Leukopenia—Entecavir—hepatitis B	0.00317	0.00662	CcSEcCtD
Mefloquine—Sleep disorder—Lamivudine—hepatitis B	0.00314	0.00657	CcSEcCtD
Mefloquine—Deafness—Lamivudine—hepatitis B	0.00304	0.00636	CcSEcCtD
Mefloquine—Mediastinal disorder—Telbivudine—hepatitis B	0.00301	0.00629	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00299	0.00625	CcSEcCtD
Mefloquine—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00294	0.00614	CcSEcCtD
Mefloquine—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00294	0.00614	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00292	0.0061	CcSEcCtD
Mefloquine—Malnutrition—Telbivudine—hepatitis B	0.00291	0.00608	CcSEcCtD
Mefloquine—Anaphylactic shock—Entecavir—hepatitis B	0.00289	0.00604	CcSEcCtD
Mefloquine—Nervous system disorder—Entecavir—hepatitis B	0.00283	0.00592	CcSEcCtD
Mefloquine—Skin disorder—Entecavir—hepatitis B	0.00281	0.00586	CcSEcCtD
Mefloquine—Muscle spasms—Telbivudine—hepatitis B	0.0028	0.00584	CcSEcCtD
Mefloquine—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00277	0.00578	CcSEcCtD
Mefloquine—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00276	0.00577	CcSEcCtD
Mefloquine—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00274	0.00572	CcSEcCtD
Mefloquine—Ill-defined disorder—Telbivudine—hepatitis B	0.0027	0.00564	CcSEcCtD
Mefloquine—Affect lability—Lamivudine—hepatitis B	0.00268	0.0056	CcSEcCtD
Mefloquine—CYP19A1—liver—hepatitis B	0.00266	0.0149	CbGeAlD
Mefloquine—Malaise—Telbivudine—hepatitis B	0.00262	0.00548	CcSEcCtD
Mefloquine—Insomnia—Entecavir—hepatitis B	0.00261	0.00546	CcSEcCtD
Mefloquine—Mood swings—Lamivudine—hepatitis B	0.00258	0.00539	CcSEcCtD
Mefloquine—Somnolence—Entecavir—hepatitis B	0.00257	0.00537	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00257	0.00537	CcSEcCtD
Mefloquine—Dyspepsia—Entecavir—hepatitis B	0.00254	0.00531	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Entecavir—hepatitis B	0.00249	0.00521	CcSEcCtD
Mefloquine—Fatigue—Entecavir—hepatitis B	0.00249	0.0052	CcSEcCtD
Mefloquine—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00248	0.00518	CcSEcCtD
Mefloquine—Myalgia—Telbivudine—hepatitis B	0.00248	0.00517	CcSEcCtD
Mefloquine—Chest pain—Telbivudine—hepatitis B	0.00248	0.00517	CcSEcCtD
Mefloquine—Arthralgia—Telbivudine—hepatitis B	0.00248	0.00517	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00246	0.00514	CcSEcCtD
Mefloquine—Cramp muscle—Lamivudine—hepatitis B	0.00245	0.00512	CcSEcCtD
Mefloquine—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00245	0.00512	CcSEcCtD
Mefloquine—BCHE—blood—hepatitis B	0.00245	0.0137	CbGeAlD
Mefloquine—Discomfort—Telbivudine—hepatitis B	0.00245	0.00511	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00243	0.00508	CcSEcCtD
Mefloquine—Muscular weakness—Lamivudine—hepatitis B	0.0024	0.00501	CcSEcCtD
Mefloquine—Gastrointestinal pain—Entecavir—hepatitis B	0.00236	0.00494	CcSEcCtD
Mefloquine—Nervous system disorder—Telbivudine—hepatitis B	0.00233	0.00486	CcSEcCtD
Mefloquine—Thrombocytopenia—Telbivudine—hepatitis B	0.00232	0.00485	CcSEcCtD
Mefloquine—Skin disorder—Telbivudine—hepatitis B	0.00231	0.00482	CcSEcCtD
Mefloquine—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00231	0.00482	CcSEcCtD
Mefloquine—Abdominal pain—Entecavir—hepatitis B	0.00228	0.00477	CcSEcCtD
Mefloquine—Body temperature increased—Entecavir—hepatitis B	0.00228	0.00477	CcSEcCtD
Mefloquine—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00223	0.00466	CcSEcCtD
Mefloquine—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00223	0.00466	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00216	0.00452	CcSEcCtD
Mefloquine—Insomnia—Telbivudine—hepatitis B	0.00215	0.00448	CcSEcCtD
Mefloquine—Paraesthesia—Telbivudine—hepatitis B	0.00213	0.00445	CcSEcCtD
Mefloquine—Dyspepsia—Telbivudine—hepatitis B	0.00209	0.00436	CcSEcCtD
Mefloquine—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00208	0.00434	CcSEcCtD
Mefloquine—Asthenia—Entecavir—hepatitis B	0.00207	0.00433	CcSEcCtD
Mefloquine—Renal failure—Lamivudine—hepatitis B	0.00206	0.00431	CcSEcCtD
Mefloquine—Neuropathy peripheral—Lamivudine—hepatitis B	0.00206	0.00429	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00205	0.00428	CcSEcCtD
Mefloquine—Fatigue—Telbivudine—hepatitis B	0.00205	0.00427	CcSEcCtD
Mefloquine—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00202	0.00423	CcSEcCtD
Mefloquine—Sweating—Lamivudine—hepatitis B	0.00201	0.0042	CcSEcCtD
Mefloquine—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00199	0.00417	CcSEcCtD
Mefloquine—Hepatobiliary disease—Lamivudine—hepatitis B	0.00198	0.00414	CcSEcCtD
Mefloquine—Diarrhoea—Entecavir—hepatitis B	0.00198	0.00413	CcSEcCtD
Mefloquine—Agranulocytosis—Lamivudine—hepatitis B	0.00196	0.00409	CcSEcCtD
Mefloquine—Feeling abnormal—Telbivudine—hepatitis B	0.00196	0.00409	CcSEcCtD
Mefloquine—Gastrointestinal pain—Telbivudine—hepatitis B	0.00194	0.00405	CcSEcCtD
Mefloquine—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00193	0.00403	CcSEcCtD
Mefloquine—BCHE—liver—hepatitis B	0.00192	0.0108	CbGeAlD
Mefloquine—Dizziness—Entecavir—hepatitis B	0.00191	0.00399	CcSEcCtD
Mefloquine—Abdominal pain—Telbivudine—hepatitis B	0.00188	0.00392	CcSEcCtD
Mefloquine—Body temperature increased—Telbivudine—hepatitis B	0.00188	0.00392	CcSEcCtD
Mefloquine—Connective tissue disorder—Lamivudine—hepatitis B	0.00185	0.00386	CcSEcCtD
Mefloquine—Vomiting—Entecavir—hepatitis B	0.00184	0.00384	CcSEcCtD
Mefloquine—Rash—Entecavir—hepatitis B	0.00182	0.00381	CcSEcCtD
Mefloquine—Dermatitis—Entecavir—hepatitis B	0.00182	0.0038	CcSEcCtD
Mefloquine—Headache—Entecavir—hepatitis B	0.00181	0.00378	CcSEcCtD
Mefloquine—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00179	0.00374	CcSEcCtD
Mefloquine—Erythema multiforme—Lamivudine—hepatitis B	0.00178	0.00372	CcSEcCtD
Mefloquine—Rash—Adefovir Dipivoxil—hepatitis B	0.00178	0.00371	CcSEcCtD
Mefloquine—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00178	0.00371	CcSEcCtD
Mefloquine—Headache—Adefovir Dipivoxil—hepatitis B	0.00177	0.00369	CcSEcCtD
Mefloquine—CYP3A4—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.00175	0.00511	CbGpPWpGaD
Mefloquine—Nausea—Entecavir—hepatitis B	0.00172	0.00359	CcSEcCtD
Mefloquine—Asthenia—Telbivudine—hepatitis B	0.0017	0.00356	CcSEcCtD
Mefloquine—Mediastinal disorder—Lamivudine—hepatitis B	0.0017	0.00354	CcSEcCtD
Mefloquine—Chills—Lamivudine—hepatitis B	0.00169	0.00353	CcSEcCtD
Mefloquine—Pruritus—Telbivudine—hepatitis B	0.00168	0.00351	CcSEcCtD
Mefloquine—Nausea—Adefovir Dipivoxil—hepatitis B	0.00167	0.0035	CcSEcCtD
Mefloquine—Alopecia—Lamivudine—hepatitis B	0.00166	0.00348	CcSEcCtD
Mefloquine—CYP3A4—blood—hepatitis B	0.00165	0.00926	CbGeAlD
Mefloquine—Erythema—Lamivudine—hepatitis B	0.00164	0.00342	CcSEcCtD
Mefloquine—Malnutrition—Lamivudine—hepatitis B	0.00164	0.00342	CcSEcCtD
Mefloquine—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.00163	0.00475	CbGpPWpGaD
Mefloquine—Diarrhoea—Telbivudine—hepatitis B	0.00162	0.00339	CcSEcCtD
Mefloquine—CYP2D6—blood—hepatitis B	0.00162	0.00911	CbGeAlD
Mefloquine—Muscle spasms—Lamivudine—hepatitis B	0.00158	0.00329	CcSEcCtD
Mefloquine—HBA1—Folate Metabolism—TP53—hepatitis B	0.00157	0.00459	CbGpPWpGaD
Mefloquine—Dizziness—Telbivudine—hepatitis B	0.00157	0.00328	CcSEcCtD
Mefloquine—CYP2D6—Xenobiotics—CYP2A6—hepatitis B	0.00156	0.00454	CbGpPWpGaD
Mefloquine—Tremor—Lamivudine—hepatitis B	0.00154	0.00321	CcSEcCtD
Mefloquine—Ill-defined disorder—Lamivudine—hepatitis B	0.00152	0.00318	CcSEcCtD
Mefloquine—Vomiting—Telbivudine—hepatitis B	0.00151	0.00315	CcSEcCtD
Mefloquine—CYP2D6—Tamoxifen metabolism—CYP2A6—hepatitis B	0.0015	0.00437	CbGpPWpGaD
Mefloquine—Rash—Telbivudine—hepatitis B	0.0015	0.00313	CcSEcCtD
Mefloquine—Dermatitis—Telbivudine—hepatitis B	0.0015	0.00312	CcSEcCtD
Mefloquine—Headache—Telbivudine—hepatitis B	0.00149	0.00311	CcSEcCtD
Mefloquine—Malaise—Lamivudine—hepatitis B	0.00148	0.00309	CcSEcCtD
Mefloquine—Vertigo—Lamivudine—hepatitis B	0.00147	0.00308	CcSEcCtD
Mefloquine—Syncope—Lamivudine—hepatitis B	0.00147	0.00307	CcSEcCtD
Mefloquine—Leukopenia—Lamivudine—hepatitis B	0.00147	0.00306	CcSEcCtD
Mefloquine—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00145	0.00423	CbGpPWpGaD
Mefloquine—Loss of consciousness—Lamivudine—hepatitis B	0.00144	0.00301	CcSEcCtD
Mefloquine—HBA1—Folate Metabolism—IL6—hepatitis B	0.00144	0.0042	CbGpPWpGaD
Mefloquine—CYP19A1—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.00143	0.00417	CbGpPWpGaD
Mefloquine—Convulsion—Lamivudine—hepatitis B	0.00142	0.00297	CcSEcCtD
Mefloquine—HBA1—Selenium Micronutrient Network—TNF—hepatitis B	0.00142	0.00413	CbGpPWpGaD
Mefloquine—Nausea—Telbivudine—hepatitis B	0.00141	0.00295	CcSEcCtD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—RIT2—hepatitis B	0.0014	0.00409	CbGpPWpGaD
Mefloquine—Arthralgia—Lamivudine—hepatitis B	0.0014	0.00291	CcSEcCtD
Mefloquine—Chest pain—Lamivudine—hepatitis B	0.0014	0.00291	CcSEcCtD
Mefloquine—Myalgia—Lamivudine—hepatitis B	0.0014	0.00291	CcSEcCtD
Mefloquine—Anxiety—Lamivudine—hepatitis B	0.00139	0.0029	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00139	0.00289	CcSEcCtD
Mefloquine—Discomfort—Lamivudine—hepatitis B	0.00138	0.00288	CcSEcCtD
Mefloquine—Confusional state—Lamivudine—hepatitis B	0.00135	0.00282	CcSEcCtD
Mefloquine—Anaphylactic shock—Lamivudine—hepatitis B	0.00134	0.00279	CcSEcCtD
Mefloquine—Oedema—Lamivudine—hepatitis B	0.00134	0.00279	CcSEcCtD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—APOBEC3G—hepatitis B	0.00132	0.00384	CbGpPWpGaD
Mefloquine—Shock—Lamivudine—hepatitis B	0.00132	0.00275	CcSEcCtD
Mefloquine—HBA2—Metabolism—AKR1B1—hepatitis B	0.00131	0.00383	CbGpPWpGaD
Mefloquine—Nervous system disorder—Lamivudine—hepatitis B	0.00131	0.00274	CcSEcCtD
Mefloquine—Thrombocytopenia—Lamivudine—hepatitis B	0.00131	0.00274	CcSEcCtD
Mefloquine—Skin disorder—Lamivudine—hepatitis B	0.0013	0.00271	CcSEcCtD
Mefloquine—Hyperhidrosis—Lamivudine—hepatitis B	0.00129	0.0027	CcSEcCtD
Mefloquine—CYP3A4—liver—hepatitis B	0.00129	0.00724	CbGeAlD
Mefloquine—CYP2D6—liver—hepatitis B	0.00127	0.00712	CbGeAlD
Mefloquine—HBA2—Metabolism—GGT2—hepatitis B	0.00126	0.00367	CbGpPWpGaD
Mefloquine—Hypotension—Lamivudine—hepatitis B	0.00125	0.00261	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00122	0.00255	CcSEcCtD
Mefloquine—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.00122	0.00355	CbGpPWpGaD
Mefloquine—Insomnia—Lamivudine—hepatitis B	0.00121	0.00253	CcSEcCtD
Mefloquine—Paraesthesia—Lamivudine—hepatitis B	0.0012	0.00251	CcSEcCtD
Mefloquine—Dyspnoea—Lamivudine—hepatitis B	0.00119	0.00249	CcSEcCtD
Mefloquine—Somnolence—Lamivudine—hepatitis B	0.00119	0.00248	CcSEcCtD
Mefloquine—Dyspepsia—Lamivudine—hepatitis B	0.00118	0.00246	CcSEcCtD
Mefloquine—CYP19A1—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00118	0.00343	CbGpPWpGaD
Mefloquine—ABCB1—blood—hepatitis B	0.00117	0.00655	CbGeAlD
Mefloquine—Decreased appetite—Lamivudine—hepatitis B	0.00116	0.00243	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00116	0.00241	CcSEcCtD
Mefloquine—Fatigue—Lamivudine—hepatitis B	0.00115	0.00241	CcSEcCtD
Mefloquine—HBA1—Selenium Micronutrient Network—IL6—hepatitis B	0.00114	0.00333	CbGpPWpGaD
Mefloquine—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00114	0.00331	CbGpPWpGaD
Mefloquine—Feeling abnormal—Lamivudine—hepatitis B	0.0011	0.0023	CcSEcCtD
Mefloquine—Gastrointestinal pain—Lamivudine—hepatitis B	0.00109	0.00228	CcSEcCtD
Mefloquine—ADORA2A—Signaling by NGF—RIT2—hepatitis B	0.00108	0.00314	CbGpPWpGaD
Mefloquine—Urticaria—Lamivudine—hepatitis B	0.00106	0.00222	CcSEcCtD
Mefloquine—CYP19A1—Metapathway biotransformation—AKR1B1—hepatitis B	0.00106	0.00309	CbGpPWpGaD
Mefloquine—Body temperature increased—Lamivudine—hepatitis B	0.00106	0.00221	CcSEcCtD
Mefloquine—Abdominal pain—Lamivudine—hepatitis B	0.00106	0.00221	CcSEcCtD
Mefloquine—ABCB1—Allograft Rejection—HLA-DPA1—hepatitis B	0.00105	0.00306	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—KCNH1—hepatitis B	0.00105	0.00306	CbGpPWpGaD
Mefloquine—CYP19A1—Biological oxidations—GGT2—hepatitis B	0.00103	0.003	CbGpPWpGaD
Mefloquine—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	0.00102	0.00297	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—AKR1B1—hepatitis B	0.000995	0.0029	CbGpPWpGaD
Mefloquine—Hypersensitivity—Lamivudine—hepatitis B	0.000986	0.00206	CcSEcCtD
Mefloquine—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00098	0.00286	CbGpPWpGaD
Mefloquine—Asthenia—Lamivudine—hepatitis B	0.00096	0.002	CcSEcCtD
Mefloquine—HBA1—Metabolism—GGT2—hepatitis B	0.000954	0.00278	CbGpPWpGaD
Mefloquine—Pruritus—Lamivudine—hepatitis B	0.000947	0.00198	CcSEcCtD
Mefloquine—BCHE—Neuronal System—KCNH1—hepatitis B	0.000935	0.00273	CbGpPWpGaD
Mefloquine—Diarrhoea—Lamivudine—hepatitis B	0.000915	0.00191	CcSEcCtD
Mefloquine—ABCB1—liver—hepatitis B	0.000913	0.00512	CbGeAlD
Mefloquine—ACHE—Melatonin metabolism and effects—NFKB1—hepatitis B	0.00089	0.00259	CbGpPWpGaD
Mefloquine—Dizziness—Lamivudine—hepatitis B	0.000885	0.00185	CcSEcCtD
Mefloquine—Vomiting—Lamivudine—hepatitis B	0.000851	0.00178	CcSEcCtD
Mefloquine—Rash—Lamivudine—hepatitis B	0.000844	0.00176	CcSEcCtD
Mefloquine—Dermatitis—Lamivudine—hepatitis B	0.000843	0.00176	CcSEcCtD
Mefloquine—Headache—Lamivudine—hepatitis B	0.000838	0.00175	CcSEcCtD
Mefloquine—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.000829	0.00242	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Other—CCR5—hepatitis B	0.000825	0.0024	CbGpPWpGaD
Mefloquine—ADORA2A—Monoamine Transport—TNF—hepatitis B	0.000801	0.00233	CbGpPWpGaD
Mefloquine—Nausea—Lamivudine—hepatitis B	0.000795	0.00166	CcSEcCtD
Mefloquine—ACHE—ATF-2 transcription factor network—NOS2—hepatitis B	0.00079	0.0023	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—CYP2A6—hepatitis B	0.000763	0.00222	CbGpPWpGaD
Mefloquine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.0007	0.00204	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—GOT2—hepatitis B	0.00069	0.00201	CbGpPWpGaD
Mefloquine—ABCB1—HIF-1-alpha transcription factor network—HNF4A—hepatitis B	0.000677	0.00197	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000664	0.00194	CbGpPWpGaD
Mefloquine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000647	0.00189	CbGpPWpGaD
Mefloquine—ADORA1—G alpha (i) signalling events—CXCL10—hepatitis B	0.000645	0.00188	CbGpPWpGaD
Mefloquine—ACHE—Monoamine Transport—TNF—hepatitis B	0.00064	0.00186	CbGpPWpGaD
Mefloquine—CYP2D6—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000639	0.00186	CbGpPWpGaD
Mefloquine—CYP19A1—Biological oxidations—CYP2A6—hepatitis B	0.000624	0.00182	CbGpPWpGaD
Mefloquine—ACHE—ATF-2 transcription factor network—IFNG—hepatitis B	0.000606	0.00177	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—GGT1—hepatitis B	0.000596	0.00174	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—GOT1—hepatitis B	0.000596	0.00174	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—CYP2A6—hepatitis B	0.000578	0.00169	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—FAS—hepatitis B	0.000562	0.00164	CbGpPWpGaD
Mefloquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000525	0.00153	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—GOT2—hepatitis B	0.000523	0.00152	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000513	0.00149	CbGpPWpGaD
Mefloquine—ADORA1—G alpha (i) signalling events—CCR5—hepatitis B	0.0005	0.00146	CbGpPWpGaD
Mefloquine—CYP19A1—Biological oxidations—GGT1—hepatitis B	0.000487	0.00142	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—HLA-DPB1—hepatitis B	0.000482	0.0014	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—NOS2—hepatitis B	0.00048	0.0014	CbGpPWpGaD
Mefloquine—CYP2D6—Metapathway biotransformation—AKR1B1—hepatitis B	0.000473	0.00138	CbGpPWpGaD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.000464	0.00135	CbGpPWpGaD
Mefloquine—CYP2D6—Biological oxidations—GGT2—hepatitis B	0.00046	0.00134	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—GGT1—hepatitis B	0.000451	0.00132	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—GOT1—hepatitis B	0.000451	0.00132	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000449	0.00131	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—FAS—hepatitis B	0.000434	0.00126	CbGpPWpGaD
Mefloquine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000423	0.00123	CbGpPWpGaD
Mefloquine—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000418	0.00122	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000413	0.0012	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000401	0.00117	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000398	0.00116	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000396	0.00115	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—CXCL10—hepatitis B	0.00039	0.00114	CbGpPWpGaD
Mefloquine—ACHE—Peptide hormone metabolism—CTNNB1—hepatitis B	0.000388	0.00113	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.000374	0.00109	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—NOS2—hepatitis B	0.000371	0.00108	CbGpPWpGaD
Mefloquine—CYP2D6—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000365	0.00106	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000361	0.00105	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.000358	0.00104	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—IL10—hepatitis B	0.000355	0.00104	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—CD40LG—hepatitis B	0.000355	0.00104	CbGpPWpGaD
Mefloquine—BCHE—Peptide hormone metabolism—CTNNB1—hepatitis B	0.000346	0.00101	CbGpPWpGaD
Mefloquine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000343	0.001	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000341	0.000995	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—FASLG—hepatitis B	0.00033	0.000962	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—FAS—hepatitis B	0.000318	0.000928	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—ALB—hepatitis B	0.000317	0.000924	CbGpPWpGaD
Mefloquine—ACHE—ATF-2 transcription factor network—IL6—hepatitis B	0.000316	0.000923	CbGpPWpGaD
Mefloquine—ABCB1—HIF-1-alpha transcription factor network—NOS2—hepatitis B	0.000314	0.000916	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—HLA-A—hepatitis B	0.000313	0.000912	CbGpPWpGaD
Mefloquine—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.000309	0.000902	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—PTEN—hepatitis B	0.000308	0.000898	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000307	0.000895	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—CCR5—hepatitis B	0.000303	0.000883	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—CXCL10—hepatitis B	0.000301	0.000879	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—GGT2—hepatitis B	0.000301	0.000877	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—SAG—hepatitis B	0.0003	0.000874	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—RIT2—hepatitis B	0.0003	0.000874	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000289	0.000843	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—HLA-DRB1—hepatitis B	0.000286	0.000833	CbGpPWpGaD
Mefloquine—CYP2D6—Biological oxidations—CYP2A6—hepatitis B	0.000279	0.000812	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000263	0.000768	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—F2—hepatitis B	0.00026	0.000757	CbGpPWpGaD
Mefloquine—ACHE—Phospholipid metabolism—PTEN—hepatitis B	0.000257	0.000748	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—PTEN—hepatitis B	0.000242	0.000705	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—ALB—hepatitis B	0.00024	0.0007	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—PTEN—hepatitis B	0.000238	0.000693	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—CCR5—hepatitis B	0.000234	0.000682	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—CDKN1A—hepatitis B	0.000234	0.000682	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PTEN—hepatitis B	0.000233	0.00068	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SAG—hepatitis B	0.000232	0.000675	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—RIT2—hepatitis B	0.000232	0.000675	CbGpPWpGaD
Mefloquine—BCHE—Phospholipid metabolism—PTEN—hepatitis B	0.000229	0.000668	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—hepatitis B	0.000225	0.000657	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—CXCL10—hepatitis B	0.000221	0.000643	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—PTEN—hepatitis B	0.00022	0.00064	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—hepatitis B	0.000218	0.000637	CbGpPWpGaD
Mefloquine—CYP2D6—Biological oxidations—GGT1—hepatitis B	0.000218	0.000634	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—TP53—hepatitis B	0.00021	0.000613	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—IFNG—hepatitis B	0.000209	0.000609	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—HSPA5—hepatitis B	0.000209	0.000608	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000204	0.000594	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000203	0.000592	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—F2—hepatitis B	0.000201	0.000585	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CXCL10—hepatitis B	0.0002	0.000584	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—AKR1B1—hepatitis B	0.0002	0.000583	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000198	0.000578	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000198	0.000577	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000197	0.000574	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—IL6—hepatitis B	0.000192	0.000561	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GGT2—hepatitis B	0.000192	0.000559	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000187	0.000546	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—HSPA5—hepatitis B	0.000186	0.000542	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—IL2—hepatitis B	0.000186	0.000541	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—AKR1B1—hepatitis B	0.000184	0.000536	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—PTEN—hepatitis B	0.000183	0.000534	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	0.000182	0.000531	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000182	0.00053	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—CDKN1A—hepatitis B	0.00018	0.000524	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—PTEN—hepatitis B	0.000179	0.000523	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—NFKB1—hepatitis B	0.000179	0.00052	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—AKR1B1—hepatitis B	0.000178	0.00052	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GGT2—hepatitis B	0.000176	0.000514	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—CCR5—hepatitis B	0.000171	0.000499	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GGT2—hepatitis B	0.000171	0.000499	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CXCL10—hepatitis B	0.00017	0.000497	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000164	0.000478	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.000163	0.000475	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—TP53—hepatitis B	0.000162	0.000473	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000157	0.000458	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CCR5—hepatitis B	0.000155	0.000453	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CXCL10—hepatitis B	0.000155	0.000451	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000153	0.000447	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—TP53—hepatitis B	0.00015	0.000437	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—IL6—hepatitis B	0.000149	0.000433	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—F2—hepatitis B	0.000147	0.000428	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—hepatitis B	0.000146	0.000425	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—TGFB1—hepatitis B	0.000145	0.000422	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—GGT1—hepatitis B	0.000142	0.000415	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—TNF—hepatitis B	0.000135	0.000394	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.000135	0.000394	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—F2—hepatitis B	0.000133	0.000389	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CCR5—hepatitis B	0.000132	0.000385	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CCR5—hepatitis B	0.00012	0.00035	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CXCL10—hepatitis B	0.000118	0.000345	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CYP2A6—hepatitis B	0.000116	0.000339	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—F2—hepatitis B	0.000113	0.00033	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—F2—hepatitis B	0.000113	0.000329	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—IL6—hepatitis B	0.000112	0.000327	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000108	0.000316	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CYP2A6—hepatitis B	0.000107	0.000311	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GOT2—hepatitis B	0.000105	0.000306	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CYP2A6—hepatitis B	0.000104	0.000302	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—F2—hepatitis B	0.000103	0.0003	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—F2—hepatitis B	0.000101	0.000293	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	9.95e-05	0.00029	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—IL2—hepatitis B	9.89e-05	0.000288	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—ALB—hepatitis B	9.66e-05	0.000282	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GOT2—hepatitis B	9.66e-05	0.000281	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GOT2—hepatitis B	9.37e-05	0.000273	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCR5—hepatitis B	9.18e-05	0.000268	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CXCL10—hepatitis B	9.14e-05	0.000266	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GOT1—hepatitis B	9.07e-05	0.000264	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GGT1—hepatitis B	9.07e-05	0.000264	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—IL2—hepatitis B	8.98e-05	0.000262	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	8.84e-05	0.000258	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—AKR1B1—hepatitis B	8.71e-05	0.000254	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	8.63e-05	0.000252	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	8.62e-05	0.000251	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	8.57e-05	0.00025	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GGT2—hepatitis B	8.35e-05	0.000243	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GOT1—hepatitis B	8.33e-05	0.000243	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GGT1—hepatitis B	8.33e-05	0.000243	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	8.27e-05	0.000241	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—AKR1B1—hepatitis B	8.2e-05	0.000239	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GGT1—hepatitis B	8.09e-05	0.000236	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GOT1—hepatitis B	8.09e-05	0.000236	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—F2—hepatitis B	7.88e-05	0.00023	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GGT2—hepatitis B	7.87e-05	0.000229	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—IL2—hepatitis B	7.63e-05	0.000223	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	7.6e-05	0.000221	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	7.37e-05	0.000215	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—CTNNB1—hepatitis B	7.33e-05	0.000214	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	7.14e-05	0.000208	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCR5—hepatitis B	7.09e-05	0.000207	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—IL2—hepatitis B	6.93e-05	0.000202	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	6.67e-05	0.000194	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—CTNNB1—hepatitis B	6.54e-05	0.000191	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—F2—hepatitis B	6.08e-05	0.000177	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	5.88e-05	0.000171	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—AKR1B1—hepatitis B	5.36e-05	0.000156	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IL2—hepatitis B	5.3e-05	0.000155	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—IL6—hepatitis B	5.28e-05	0.000154	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GGT2—hepatitis B	5.14e-05	0.00015	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CTNNB1—hepatitis B	5.12e-05	0.000149	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYP2A6—hepatitis B	5.06e-05	0.000147	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CDKN1A—hepatitis B	5e-05	0.000146	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PTEN—hepatitis B	4.99e-05	0.000145	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NFKB1—hepatitis B	4.97e-05	0.000145	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ALB—hepatitis B	4.82e-05	0.000141	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CYP2A6—hepatitis B	4.77e-05	0.000139	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GOT2—hepatitis B	4.57e-05	0.000133	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	4.48e-05	0.000131	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ALB—hepatitis B	4.43e-05	0.000129	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GOT2—hepatitis B	4.31e-05	0.000126	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ALB—hepatitis B	4.3e-05	0.000125	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TGFB1—hepatitis B	4.14e-05	0.000121	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IL2—hepatitis B	4.1e-05	0.000119	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—IL6—hepatitis B	4.07e-05	0.000119	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CTNNB1—hepatitis B	3.95e-05	0.000115	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GGT1—hepatitis B	3.95e-05	0.000115	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GOT1—hepatitis B	3.95e-05	0.000115	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CDKN1A—hepatitis B	3.86e-05	0.000113	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PTEN—hepatitis B	3.85e-05	0.000112	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NFKB1—hepatitis B	3.83e-05	0.000112	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GOT1—hepatitis B	3.72e-05	0.000108	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GGT1—hepatitis B	3.72e-05	0.000108	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PTEN—hepatitis B	3.68e-05	0.000107	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TP53—hepatitis B	3.41e-05	9.93e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PTEN—hepatitis B	3.38e-05	9.86e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PTEN—hepatitis B	3.28e-05	9.57e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TGFB1—hepatitis B	3.19e-05	9.31e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IL6—hepatitis B	3.12e-05	9.09e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYP2A6—hepatitis B	3.12e-05	9.08e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GOT2—hepatitis B	2.82e-05	8.21e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TP53—hepatitis B	2.63e-05	7.67e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GGT1—hepatitis B	2.43e-05	7.09e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GOT1—hepatitis B	2.43e-05	7.09e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IL6—hepatitis B	2.41e-05	7.02e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ALB—hepatitis B	2.1e-05	6.12e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ALB—hepatitis B	1.98e-05	5.77e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PTEN—hepatitis B	1.6e-05	4.67e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PTEN—hepatitis B	1.51e-05	4.4e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ALB—hepatitis B	1.29e-05	3.77e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PTEN—hepatitis B	9.87e-06	2.88e-05	CbGpPWpGaD
